… to treat multiple ophthalmology conditions. Biocon Biologics, Regeneron and Bayer … , CEO & Managing Director, Biocon Biologics, said, "This settlement … 00. Source : Equity Bulls Keywords Biocon INE376G01013 Biotechnology Settlement License Agreement …

… has advised Indian biopharmaceutical company Biocon on its $1.2 billion … Fund II and True North. Biocon, which had earlier been pushing …

Bengaluru: Biocon Group Chairperson, Kiran Mazumdar-Shaw … recognition is a reaffirmation of Biocon’s purpose-driven journey to … the leading drugmakers in India. Biocon’s leadership in the biosimilars …

… deal in which which Biocon Ltd will integrate Biocon Biologics Ltd as …

… inside-out. Infosys, Godrej, and Biocon have leveraged internal storytelling to …

… the July 2025 approval of Biocon Biologics’ Kirsty (insulin aspart-xjhz …

… , Samsung Bioepis, Fresenius Kabi, Zentiva, Biocon Biologics, and Accord. On December … 2025. On December 2, 2025: Biocon Biologics announced the market entry …

… Kiran Mazumdar Shaw, chairperson of Biocon, was honored with the … Shaw (founder and chairperson of Biocon Group), Yannis Yortsos (Dean of … . Her journey-from founding Biocon in 1978 to its emergence … called the award confirmation that Biocon's quest " …

… Reimbursement Drug List pathway. 4. Biocon buys out Viatris and others … in the biosimilar outfit Biocon Biologics back to Biocon for $815 million … . Together with other equity buyouts, Biocon can fully integrate its biosimilar …

… , in collaboration with AIIMS, ARTPARK, Biocon Foundation, BITS Pilani (Goa), KLE …